Short-time pretreatment of rosuvastatin attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 4946-4948

  Wu, Bing ^a   Su, Zhijun ^a   Lin, Rong ^a   Dai, Ruozhu ^a   Chen, Chengbo ^a   Wu, Haiyun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

High mobility group box 1 protein; Myocardial ischemia; Reperfusion; Rosuvastatin

Indexed keywords

ATORVASTATIN; CREATINE KINASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPARIN; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; ROSUVASTATIN; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MALONALDEHYDE; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROCARDIOGRAM; ELECTRODE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOBLOTTING; INFLAMMATORY CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LETTER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ST SEGMENT ELEVATION; ANIMAL; DRUG EFFECTS; METABOLISM; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; PREMEDICATION; SPRAGUE DAWLEY RAT;

ANIMALS; BIOLOGICAL MARKERS; FLUOROBENZENES; HMGB1 PROTEIN; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MALONDIALDEHYDE; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; PREMEDICATION; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SULFONAMIDES; SUPEROXIDE DISMUTASE;

EID: 84886381877     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.074     Document Type: Article

References (22)

1. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195
2. C.W. Bell, W. Jiang, and C.F. Reich The extracellular release of HMGB1 during apoptotic cell death Am J Physiol Cell Physiol 291 2006 C1318 C1325
3. M. Andrassy, H.C. Volz, and J.C. Igwe High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 2008 3216 3226
4. X. Hu, H. Jiang, and Q. Bai Increased serum HMGB1 is related to the severity of coronary artery stenosis Clin Chim Acta 406 2009 139 142
5. M. Andrassy, H.C. Volz, and N. Riedle HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction J Intern Med 270 2011 245 253
6. D. Zhao, Y. Wang, and Y. Xu Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation Int J Cardiol 158 2012 471 472
7. N.G. Frangoginis, C.W. Smith, and M.L. Entman The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31 47
8. X. Hu, W. Fu, and H. Jiang HMGB1: a potential therapeutic target for myocardial ischemia and reperfusion injury Int J Cardiol 155 2012 489-489
9. S.P. Jones, M.F. Gibson, and D.M. Rimmer Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor J Am Coll Cardiol 40 2002 1172 1178
10. M.R. Nangle, M.A. Cotter, and N.E. Cameron Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering Diabetes 52 2003 2396 2402
11. D. Susic, J. Varagic, and J. Ahn Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models J Am Coll Cardiol 42 2003 1091 1097
12. E.O. Weinberg, M. Scherrer-Crosbie, and M.H. Picard Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion Am J Physiol Heart Circ Physiol 288 2005 H1802 H1809
13. L Fan Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury Coron Artery Dis 24 4 2013 Jun 334 341
14. L. Wang, X. Zhang, and L. Liu Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression Neurosci Lett 471 2010 152 156
15. D. Jin, Y. Wu, and L. Zhao Atorvastatin inhibits serum HMGB1 level in patients with hyperlipidemia Exp Ther Med 4 2012 1124 1126
16. B. Wu, R. Lin, and R. Dai Valsartan attenuates oxidative stress and NF-κB activation and reduces myocardial apoptosis after ischemia and reperfusion Eur J Pharmacol 705 2013 140 147
17. F. McTaggart, L. Buckett, and R. Davidson Preclinical and clinical pharma-cology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Am J Cardiol 87 2001 28 32
18. X. Hu, C. Xu, and X. Zhou PI3K/Akt signaling pathway involved in cardioprotection of preconditioning with high mobility group box 1 protein during myocardial ischemia and reperfusion Int J Cardiol 150 2011 222 223
19. J. Yang, C. Huang, and J. Yang Statins attenuates high mobility group box-1 protein induced vascular endothelial activation: a key role for TLR4/NF-κB signaling pathway Mol Cell Biochem 345 2010 189 195
20. H.S. Ding, J. Yang, and F.L. Gong High mobility group box 1 mediates neutrophil recruitment in myocardial ischemia-reperfusion injury through toll like receptor 4-related pathway Gene 509 2012 149 153
21. D. Tang, Y. Shi, and R. Kang Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 J Leukoc Biol 81 2007 741 747
22. A. Tsung, J.R. Klune, and X. Zhang HMGB1 release induced by liver ischemia involves toll-like receptor 4-depedent reactive oxygen species production and calcium-mediated signaling J Exp Med 204 2007 2913 2923